Nitroxide radical-containing nanoparticles attenuate tumorigenic potential of triple negative breast cancer

Area of Science:

• Nanomedicine
• Cancer Biology
• Oxidative Stress Research

Background:

• Reactive oxygen species (ROS) are crucial in cancer development and survival.
• Oxidative stress plays a pivotal role in various cancers, making antioxidant therapy a promising strategy.
• Current low molecular weight antioxidants have limitations in cancer treatment.

Purpose of the Study:

• To synthesize and evaluate ROS scavenging nitroxide radical-containing nanoparticles (RNPs) for cancer therapy.
• To investigate the efficacy of RNPs in impeding the proliferative and metastatic characteristics of triple-negative breast cancer (MDA-MB-231) cells in vitro and in vivo.
• To compare the therapeutic potential and adverse effects of RNPs with conventional antioxidants like TEMPOL.

Main Methods:

• Synthesis of pH-insensitive (RNP^O) and pH-sensitive (RNP^N) nitroxide radical-containing nanoparticles.
• In vitro assessment of RNPs on the proliferative, clonogenic, migratory, and invasive potential of MDA-MB-231 and MCF-7 cell lines.
• In vivo evaluation of RNPs in an MDA-MB-231 mouse xenograft model to determine anti-tumor and anti-metastatic effects.

Main Results:

• RNPs significantly reduced the proliferation and clonogenic potential of breast cancer cell lines.
• RNPs inhibited ROS-mediated migration and invasion by downregulating NF-κB and MMP-2.
• RNPs demonstrated significant anti-tumor and anti-metastatic activity in vivo with minimal adverse effects compared to TEMPOL.

Conclusions:

• Nitroxide radical-containing nanoparticles are effective in combating ROS-induced cancer progression.
• Nanoparticle-based therapeutics offer a promising alternative to low molecular weight antioxidants for cancer treatment.
• RNPs hold potential for curtailing ROS-induced tumorigenesis in various cancers.